These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36357073)

  • 21. Cryo-Electron Microscopy: Moving Beyond X-Ray Crystal Structures for Drug Receptors and Drug Development.
    García-Nafría J; Tate CG
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():51-71. PubMed ID: 31348870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-protein coupled receptors: advances in simulation and drug discovery.
    Miao Y; McCammon JA
    Curr Opin Struct Biol; 2016 Dec; 41():83-89. PubMed ID: 27344006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biophysical investigations of class A GPCRs.
    Casiraghi M
    Biochimie; 2023 Feb; 205():86-94. PubMed ID: 36220484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible G Protein βγ9 Distribution-Based Assay Reveals Molecular Underpinnings in Subcellular, Single-Cell, and Multicellular GPCR and G Protein Activity.
    Senarath K; Ratnayake K; Siripurapu P; Payton JL; Karunarathne A
    Anal Chem; 2016 Dec; 88(23):11450-11459. PubMed ID: 27778511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent progress in assays for GPCR drug discovery.
    Guo S; Zhao T; Yun Y; Xie X
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C583-C594. PubMed ID: 35816640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting the structural features of β-arrestins as multifunctional proteins.
    Yun Y; Ji J; Lee HH
    Biochim Biophys Acta Proteins Proteom; 2021 Apr; 1869(4):140603. PubMed ID: 33421644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring GPCR conformational dynamics using single-molecule fluorescence.
    Agyemang E; Gonneville AN; Tiruvadi-Krishnan S; Lamichhane R
    Methods; 2024 Jun; 226():35-48. PubMed ID: 38604413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation.
    Lopez-Balastegui M; Stepniewski TM; Kogut-Günthel MM; Di Pizio A; Rosenkilde MM; Mao J; Selent J
    Br J Pharmacol; 2024 Jul; ():. PubMed ID: 38978399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.
    Rahman MM; Islam MR; Mim SA; Sultana N; Chellappan DK; Dua K; Kamal MA; Sharma R; Emran TB
    Oxid Med Cell Longev; 2022; 2022():8425640. PubMed ID: 36187336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of Primary Dopaminergic Midbrain Neurons Through Impact of Small Molecules Using Virtual Screening of GPR139 Supported by Molecular Dynamic Simulation and Systems Biology.
    Kaushik AC; Gautam D; Nangraj AS; Wei DQ; Sahi S
    Interdiscip Sci; 2019 Jun; 11(2):247-257. PubMed ID: 31177377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models.
    Worth CL; Kleinau G; Krause G
    PLoS One; 2009 Sep; 4(9):e7011. PubMed ID: 19756152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular dynamics techniques for modeling G protein-coupled receptors.
    McRobb FM; Negri A; Beuming T; Sherman W
    Curr Opin Pharmacol; 2016 Oct; 30():69-75. PubMed ID: 27490828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New G-protein-coupled receptor crystal structures: insights and limitations.
    Kobilka B; Schertler GF
    Trends Pharmacol Sci; 2008 Feb; 29(2):79-83. PubMed ID: 18194818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictable cholesterol binding sites in GPCRs lack consensus motifs.
    Taghon GJ; Rowe JB; Kapolka NJ; Isom DG
    Structure; 2021 May; 29(5):499-506.e3. PubMed ID: 33508215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y; Basith S; Choi S
    J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insights into emergent signaling modes of G protein-coupled receptors.
    Sutkeviciute I; Vilardaga JP
    J Biol Chem; 2020 Aug; 295(33):11626-11642. PubMed ID: 32571882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.